Inhibiting menin, either genetically with shRNAs or pharmacologically with MI-503, in Ewing sarcoma cells decreases cell proliferation, cell viability, colony formation, and tumor xenograft growth [333]. This evidence concerns the gene MEN1 and Ewing sarcoma.